Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Comparative Study of Different Treadmill Scores to Diagnose Coronary Artery Disease in a Tertiary Care Hospital

Condition:   Stable Ischemic Heart Disease
Intervention:  
Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Active, not recruiting - verified August 2016

Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)

Conditions:   Peripheral Artery Disease;   Intermittent Claudication
Interventions:   Other: Stretching exercise group;   Other: Walking training group
Sponsor:   Katholieke Universiteit Leuven
Not yet recruiting - verified August 2016

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure

Conditions:   Heart Failure;   Myocardial Infarction
Interventions:   Biological: High Dose Trivalent Influenza Vaccine;   Biological: Standard Dose Quadrivalent Influenza Vaccine
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   University of Wisconsin, Madison;   University of Toronto;   Boston VA Research Institute, Inc.;   Patient-Centered Outcomes Research Institute
Recruiting - verified August 2016

EVOLVE Short DAPT Study

Condition:   Coronary Artery Disease
Interventions:   Drug: 3 months of dual antiplatelet therapy (DAPT);   Device: SYNERGY Stent System
Sponsor:   Boston Scientific Corporation
Recruiting - verified August 2016

Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study

Conditions:   Vascular Inflammation;   Atherosclerotic Cardiovascular Disease
Interventions:   Drug: Low dose methotrexate;   Drug: Placebo
Sponsors:   Icahn School of Medicine at Mount Sinai;   Brigham and Women's Hospital;   Massachusetts General Hospital;   St. Michael's Hospital, Toronto;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2016

Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Metoprolol succinate;   Other: Placebo
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   United States Department of Defense;   University of Alabama at Birmingham
Recruiting - verified August 2016

MOMENTUM 3 IDE Clinical Study Protocol

Condition:   Advanced Refractory Left Ventricular Heart Failure
Interventions:   Device: HeartMate 3 LVAS;   Device: HeartMate II LVAS
Sponsors:   Thoratec Corporation;   St. Jude Medical
Active, not recruiting - verified August 2016

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   Cleveland Clinic Coordinating Center for Clinical Research (C5R);   Quintiles, Inc.
Recruiting - verified August 2016

Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Intervention:   Other: Slow-paced respiration therapy
Sponsor:   University of Pennsylvania
Completed - verified August 2016

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified August 2016

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

Conditions:   Diabetes, Type I;   Diabetes, Type II;   Angina;   Coronary Artery Disease
Interventions:   Drug: Ranolazine;   Drug: Placebo Pill
Sponsor:   Brigham and Women's Hospital
Completed - verified August 2016

International Survey of Acute Coronary Syndromes in Transitional Countries

Conditions:   Acute Coronary Syndrome;   Unstable Angina Pectoris;   Myocardial Infarction;   Coronary Disease
Intervention:  
Sponsor:   University of Bologna
Recruiting - verified August 2016